retatrutide trials in boston 💉 may be redefining obesity treatment. New data from TRIUMPH-1 Trial showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon

Theyre not a replacement for lifestyle modification

TRIUMPH-2 focuses on type 2 diabetes, comparing retatrutide against placebo and an active comparator in a population where glycemic control is the primary endpoint alongside weight

But wait, theres more

MARINE PLACENTAL PROTEIN A Japan-patented ingredient that comes from fresh Japanese salmon eggs

This process is key to energy metabolism and is often mentioned in contexts of physical activity, especially when energy demand increases

In contrast, caspase 3 activation, a marker for apoptotic activation, by AQ-QI and DEAQ-QI was higher without BSO pre-treatment ( Figure 4 )